Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
To compare metformin with pioglitazone in improving menstrual irregularities and
hyperandrogenism in women with PCOS so that an alternate and better treatment option will be
available for hyperinsulinemia in pcos patients.